{"id":"W4244333022","doi":"10.2165/00128413-200514710-00050","title":"Berlex has announced the Canadian approval of ethinylestradiol/drospirenone","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ethinylestradiol; Drospirenone; Pharmacy; Family medicine; Gynecology; Environmental health; Research methodology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581489,0.0004368896,0.0005118026,0.0008496013,0.002336736,0.001313955,0.0008627853,0.003256999,0.03816459],"category_scores_gemma":[0.00229834,0.0002796217,0.0006574331,0.0004358455,0.001013835,0.0003340276,0.0004462381,0.003164094,0.00591918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006938612,"about_ca_system_score_gemma":0.01421152,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2983338,"about_ca_topic_score_gemma":0.6479039,"domain_scores_codex":[0.9982051,0.0001084513,0.00004684493,0.0001248015,0.001214328,0.0003004949],"domain_scores_gemma":[0.9974324,0.0003204465,0.0001208492,0.00009780132,0.001304326,0.0007242125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002694085,0.0003003052,0.004445357,0.0004177454,0.0000787903,0.0015835,0.0001384928,0.0002382467,0.02439414,0.007137203,0.7221531,0.2364191],"study_design_scores_gemma":[0.0002412233,0.0002931752,0.004790457,0.00003913005,0.00002705903,0.0005025816,0.00005157105,0.0001525159,0.0046306,0.0002068121,0.9890426,0.00002239654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.05297332,0.07105035,0.005291701,0.2103506,0.03527297,0.001310457,0.01107395,0.003151119,0.6095256],"genre_scores_gemma":[0.1559933,0.01144413,0.006512517,0.03589882,0.002998659,0.0001193001,0.004069817,0.0003051751,0.7826583],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.7016662,"threshold_uncertainty_score":0.5931946,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03238519109358545,"score_gpt":0.2717984732535745,"score_spread":0.2394132821599891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}